John Taylor, Professor of Economics at Stanford University and developer of the "Taylor Rule" for setting interest rates | Stanford University
John Taylor, Professor of Economics at Stanford University and developer of the "Taylor Rule" for setting interest rates | Stanford University
Stanford Medicine's Center for Clinical and Translational Research and Education, known as Spectrum, has been awarded a $70 million grant from the National Institutes of Health (NIH). This funding is part of the Clinical and Translational Science Award (CTSA) program aimed at speeding up the conversion of biomedical discoveries into practical treatments that enhance patient care and public health.
Ruth O’Hara, PhD, who serves as the senior associate dean of research and holds the Lowell W. and Josephine Q. Berry Professorship in the Department of Psychiatry and Behavioral Sciences, is leading this initiative. She stated, “Stanford Medicine has been developing innovative solutions to impact the processes for turning laboratory, clinic, and community observations into interventions that improve the health of patients and the public.” O'Hara emphasized that this award will enable Stanford to better identify and implement translational research approaches to deliver treatments more swiftly to diverse populations.
The CTSA grant is significant for Stanford Medicine as it represents their largest award under this program. It marks their fourth CTSA grant since its inception. The seven-year grant extends until 2031.
With this funding, Stanford researchers will collaborate with peers from Kaiser Permanente and the University of Hawaii. The focus will be on training upcoming clinical scientists in translational research while optimizing health discoveries for community application.
The CTSA program falls under the purview of the National Center for Advancing Translational Sciences at NIH. The specific grant number assigned is 1UM1TR004921-01.
This information was initially released by Stanford School of Medicine.
Alerts Sign-up